Genomic Medicine and Environmental Toxicology

Fingerprint Dive into the research topics where Genomic Medicine and Environmental Toxicology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Lymphocytes Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Mexico Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Neurocysticercosis Medicine & Life Sciences
Epigenomics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

Airborne particulate matter induces mitotic slippage and chromosomal missegregation through disruption of the spindle assembly checkpoint (SAC)

Santibáñez-Andrade, M., Sánchez-Pérez, Y., Chirino, Y. I., Morales-Bárcenas, R., Herrera, L. A. & Garcia-Cuellar, C., Nov 1 2019, In : Chemosphere. 235, p. 794-804 11 p.

Research output: Contribution to journalArticle

M Phase Cell Cycle Checkpoints
Particulate Matter
particulate matter

Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population

Gallardo-Alvarado, L. N., Tusié-Luna, M. T., Tussié-Luna, M. I., Diaz-Chavez, J., Segura, Y. X., Bargallo-Rocha, E., Villarreal, C., Herrera, L. A., Herrera-Medina, E. M. & Cantu-De Leon, D. F., Feb 1 2019, In : BMC cancer. 19, 1, 118.

Research output: Contribution to journalArticle

Germ-Line Mutation
p53 Genes
Breast Neoplasms
Li-Fraumeni Syndrome

Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016

Ylescas-Soria, J., de la Torre-Lujan, A. H., Herrera, L. A., Miranda, D., Grimaldo, F., Rivas, S., Cervera, E., Meneses-García, A., Leon-Sarmiento, F. E. & Prada, D. G., Jun 1 2019, In : Cancer medicine. 8, 6, p. 2942-2949 8 p.

Research output: Contribution to journalArticle

Open Access
National Cancer Institute (U.S.)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Confidence Intervals